Literature DB >> 3263446

Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells.

T Ikejima1, S Okusawa, J W van der Meer, C A Dinarello.   

Abstract

A shock-like syndrome was induced in rabbits by administering toxic-shock-syndrome toxin-1 (TSST-1); tumor necrosis factor (TNF)-like activity was detected in sera of rabbits 3.5 h after injection, as measured by cytotoxic effects on the tumorigenic L929 murine fibroblast cell line. Appearance of this activity in sera coincided with onset of significant shock-related hemodynamic changes. TSST-1 stimulated release of TNF-like material from rabbit mononuclear cells in culture. Human mononuclear cells also secreted a cytotoxic substance shown to be TNF by radioimmunoassay. Maximal TNF secretion was higher in human mononuclear cells stimulated with TSST-1 than in those stimulated with bacterial lipopolysaccharide. Lipopolysaccharide, however, was a more potent inducer of interleukin-1 alpha and interleukin-1 beta from the same cells than was TSST-1. Because TNF and interleukin-1 act synergistically during induction of a shock-like state, these results suggest that part of the TSST-1-induced shock is due to production of interleukin-1 and TNF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263446     DOI: 10.1093/infdis/158.5.1017

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Steady-state staphylococcal enterotoxin type C mRNA is affected by a product of the accessory gene regulator (agr) and by glucose.

Authors:  L B Regassa; J L Couch; M J Betley
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 3.  Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules.

Authors:  R R Rich; J A Mollick; R G Cook
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

4.  Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions.

Authors:  T O Harris; M J Betley
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

5.  Production of enterotoxins and toxic shock syndrome toxin by bovine mammary isolates of Staphylococcus aureus.

Authors:  K Kenny; R F Reiser; F D Bastida-Corcuera; N L Norcross
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

6.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

7.  Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.

Authors:  C P Timmerman; E Mattsson; L Martinez-Martinez; L De Graaf; J A Van Strijp; H A Verbrugh; J Verhoef; A Fleer
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.

Authors:  L C Miller; S Isa; E Vannier; K Georgilis; A C Steere; C A Dinarello
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits.

Authors:  K Aiura; J A Gelfand; J F Burke; R C Thompson; C A Dinarello
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines.

Authors:  M Soell; M Diab; G Haan-Archipoff; A Beretz; C Herbelin; B Poutrel; J P Klein
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.